Abali, H. Et Al. 2008. Comparison of ICE (Ifosfamide-Carboplatin-Etoposide) versus DHAP (cytosine arabinoside-cisplatin-dexamethasone) as salvage chemotherapy in patients with relapsed or refractory lymphoma. Cancer Investigation , vol.26, no.4 , 401-406.

Abali, H., ÜRÜN, Y., Öksüzoǧlu, B., Budakoǧlu, B., Yüldürüm, N., Güler, T., ... Özet, G.(2008). Comparison of ICE (Ifosfamide-Carboplatin-Etoposide) versus DHAP (cytosine arabinoside-cisplatin-dexamethasone) as salvage chemotherapy in patients with relapsed or refractory lymphoma. Cancer Investigation , vol.26, no.4, 401-406.

Abali, Hüseyin Et Al. "Comparison of ICE (Ifosfamide-Carboplatin-Etoposide) versus DHAP (cytosine arabinoside-cisplatin-dexamethasone) as salvage chemotherapy in patients with relapsed or refractory lymphoma," Cancer Investigation , vol.26, no.4, 401-406, 2008

Abali, Hüseyin Et Al. "Comparison of ICE (Ifosfamide-Carboplatin-Etoposide) versus DHAP (cytosine arabinoside-cisplatin-dexamethasone) as salvage chemotherapy in patients with relapsed or refractory lymphoma." Cancer Investigation , vol.26, no.4, pp.401-406, 2008

Abali, H. Et Al. (2008) . "Comparison of ICE (Ifosfamide-Carboplatin-Etoposide) versus DHAP (cytosine arabinoside-cisplatin-dexamethasone) as salvage chemotherapy in patients with relapsed or refractory lymphoma." Cancer Investigation , vol.26, no.4, pp.401-406.

@article{article, author={Hüseyin Abali Et Al. }, title={Comparison of ICE (Ifosfamide-Carboplatin-Etoposide) versus DHAP (cytosine arabinoside-cisplatin-dexamethasone) as salvage chemotherapy in patients with relapsed or refractory lymphoma}, journal={Cancer Investigation}, year=2008, pages={401-406} }